Cardiac imaging experts have been excited about this technology for quite some time. The belief is that it could help transform how clinicians evaluate cardiovascular risk. 

New SCCT president Ronen Rubinshtein, MD, says the fields of interventional cardiology and cardiac imaging are two of his greatest interests. 

The recall was announced after testing revealed the presence of potentially harmful particulate matter. Customers were urged to return any unused vials immediately.

Former SCCT president Ed Nicol, MD, knows there has been interest in the potential of automated CT exams. However, he isn't so sure they are possible at this point in time for a number of reasons.

Work-related musculoskeletal disorders are a major safety concern in the field of echocardiography, impacting up to 90% of all cardiac sonographers.

Interventional cardiologist Yader Sandoval, MD, discusses the growing trend of using CCTA imaging to plan ahead before complex PCI procedures.

CCTA can show the regression of atherosclerosis due to drug therapies over time, so it may be a good tool to identify those patients who need of more aggressive therapy.

Computed tomography research medical physicist Cynthia McCollough, PhD, Mayo Clinic, explains the advantages of photon-counting CT systems.

In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 

Minneapolis-based Imricor Medical Systems is asking hospital leaders to rethink the way they do business.